FDA rais­es con­cerns about la­bel com­pre­hen­sion for OTC birth con­trol pill ahead of ad­comm

Per­ri­go is seek­ing to turn its dai­ly con­tra­cep­tive pill, known as Opill, in­to an over-the-counter op­tion. But ahead of a two-day ad­comm this week, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.